The Clorox Company (NYSE:CLX) Shares Bought by Amundi

Amundi grew its position in The Clorox Company (NYSE:CLX - Free Report) by 42.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,032,283 shares of the company's stock after purchasing an additional 308,234 shares during the period. Amundi owned approximately 0.83% of Clorox worth $165,816,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Los Angeles Capital Management LLC lifted its stake in shares of Clorox by 5.6% in the 3rd quarter. Los Angeles Capital Management LLC now owns 191,919 shares of the company's stock valued at $31,266,000 after purchasing an additional 10,149 shares in the last quarter. Advisors Asset Management Inc. lifted its position in Clorox by 43.4% during the 3rd quarter. Advisors Asset Management Inc. now owns 29,865 shares of the company's stock worth $4,865,000 after acquiring an additional 9,037 shares in the last quarter. Natixis Advisors LLC lifted its position in Clorox by 8.3% during the 3rd quarter. Natixis Advisors LLC now owns 63,476 shares of the company's stock worth $10,341,000 after acquiring an additional 4,839 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its position in Clorox by 1.8% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 723,906 shares of the company's stock worth $117,932,000 after acquiring an additional 13,038 shares in the last quarter. Finally, Public Employees Retirement System of Ohio lifted its position in Clorox by 26.3% during the 3rd quarter. Public Employees Retirement System of Ohio now owns 59,766 shares of the company's stock worth $9,736,000 after acquiring an additional 12,428 shares in the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Remove Ads

Clorox Stock Performance

NYSE:CLX traded down $3.04 during midday trading on Monday, reaching $147.99. 2,136,366 shares of the company traded hands, compared to its average volume of 1,211,328. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37. The firm has a market capitalization of $18.23 billion, a price-to-earnings ratio of 40.43, a price-to-earnings-growth ratio of 2.62 and a beta of 0.45. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The company has a fifty day moving average price of $155.39 and a 200 day moving average price of $160.44.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter last year, the company posted $2.16 earnings per share. On average, analysts expect that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be given a dividend of $1.22 per share. The ex-dividend date is Wednesday, April 23rd. This represents a $4.88 dividend on an annualized basis and a yield of 3.30%. Clorox's dividend payout ratio (DPR) is presently 133.33%.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the company. JPMorgan Chase & Co. lifted their price objective on Clorox from $171.00 to $173.00 and gave the stock a "neutral" rating in a report on Tuesday, February 4th. Royal Bank of Canada restated a "sector perform" rating and set a $150.00 price objective on shares of Clorox in a report on Thursday, January 30th. DA Davidson dropped their price objective on Clorox from $171.00 to $169.00 and set a "neutral" rating on the stock in a report on Wednesday, February 5th. Wells Fargo & Company lifted their price objective on Clorox from $157.00 to $161.00 and gave the stock an "equal weight" rating in a report on Tuesday, February 4th. Finally, StockNews.com downgraded Clorox from a "buy" rating to a "hold" rating in a report on Sunday, January 5th. Three equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and one has assigned a buy rating to the company's stock. According to data from MarketBeat, Clorox presently has an average rating of "Hold" and an average target price of $159.62.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.